Pliant Therapeutics Inc
NASDAQ:PLRX
During the last 3 months Pliant Therapeutics Inc insiders have not bought any shares, and sold 163.6k USD worth of shares. The stock price has increased by 9% over this period (open performance analysis).
The last transaction was made on
Jan 20, 2026
by
Kuo Minnie
, who
sold
8.9k USD
worth of 
PLRX shares.
During the last 3 months Pliant Therapeutics Inc insiders have not bought any shares, and sold 163.6k USD worth of shares. The stock price has increased by 9% over this period (open performance analysis).
The last transaction was made on
Jan 20, 2026
by
Kuo Minnie
, who
sold
8.9k USD
worth of PLRX shares.
Pliant Therapeutics Inc
Glance View
Pliant Therapeutics, Inc. engages in the business of developing and commercializing novel therapies for fibrotic diseases. The company is headquartered in South San Francisco, California and currently employs 91 full-time employees. The company went IPO on 2020-06-03. The firm is focused on discovering and developing therapies for the treatment of fibrosis and related diseases. The company focuses in treating fibrosis by inhibiting integrin-mediated activation of transforming growth factor beta (TGF-B). Its lead product candidate, PLN-74809, is an oral small-molecule, dual-selective inhibitor of avß6 and avB1. The Company’s second product candidate, PLN-1474, is a small-molecule, selective inhibitor of avB1 for treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition to its clinical programs, it is developing additional preclinical integrin-based programs. The first preclinical program is oncology program. Its second preclinical program is an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor being developed for treatment of muscular dystrophies, including duchenne muscular dystrophy.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
